SAN DIEGO, Feb. 10, 2020 /PRNewswire/ -- Halozyme
Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update
Conference Call for the fourth quarter 2019 on Monday, February 24 at 4:30 p.m. ET / 1:30 p.m.
PT. Dr. Helen Torley,
president and chief executive officer, will lead the call. On the
same date, Halozyme will release financial results for the fourth
quarter and year ended December 31,
2019 following the close of trading.
The call will be webcast live through the "Investors" section of
Halozyme's corporate website and a recording will be made available
following the close of the call. To access the webcast and
additional documents related to the call, please visit the
Investors page of www.halozyme.com approximately fifteen minutes
prior to the call to register, download and install any necessary
audio software. The live call may be accessed by dialing (877)
824-0907 (domestic callers) or (647) 689-5655 (international
callers). A telephone replay will be available after the call by
dialing (800) 585-8367 (domestic callers) or (416) 621-4642
(international callers) using replay ID number 1266162.
About Halozyme
Halozyme Therapeutics is a biotechnology
company focused on novel biological and drug
delivery approaches. Halozyme's proprietary enzyme
rHuPH20 is used to facilitate the delivery of
injected drugs and fluids and potentially
reduce the treatment burden of other drugs
to patients. Halozyme has licensed its
rHuPH20 technology, called ENHANZE®, to leading
pharmaceutical and biotechnology companies including
Roche, Baxalta, Pfizer, Janssen, AbbVie, Lilly,
Bristol-Myers Squibb, Alexion and argenx.
Halozyme derives
revenues from these collaborations in
the form of milestones and royalties as
the Company's partners make progress developing and
commercializing their products being developed with
ENHANZE®. Halozyme is headquartered in San Diego.
For more information visit www.halozyme.com.
Contact:
Al Kildani
Vice President, Investor Relations and Corporate Communications
858-704-8122
ir@halozyme.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/halozyme-to-host-fourth-quarter-and-full-year-2019-financial-results-webcast-and-conference-call-301002205.html
SOURCE Halozyme Therapeutics, Inc.